StockScan > Holders > Ra Capital Management

Ra Capital Management's Portfolio and 13F Filing

Value: $4.7B
Website: www.racap.com
CIK: 0001346824
Phone: 617-778-2500
Address: 200 Berkeley Street, 18th Floor, Boston, MA (02116)
Latest 13F Filing: 2026-08-14
Ra Capital Management's Stock Holdings & 13F Form
# Stock Name Symbol Current Price

Previous Holdings

(# Shares)

Current Holdings

(# Shares)

 Current Value Percent
1 Parabilis Medicines, Inc. Common Stock PBLS $26.85 N/A 28,933,371 $776,861,011 16.52%
2 Vaxcyte, Inc. Common Stock PCVX $66.80 N/A 11,474,599 $766,503,213 16.30%
3 Rhythm Pharmaceuticals, Inc. Common Stock RYTM $86.61 N/A 6,666,837 $577,414,753 12.28%
4 Edgewise Therapeutics, Inc. Common Stock EWTX $36.28 N/A 8,392,730 $304,488,244 6.48%
5 Septerna, Inc. Common Stock SEPN $36.42 N/A 6,995,858 $254,754,169 5.42%
6 Hemab Therapeutics Holdings, Inc. Common Stock COAG $29.80 N/A 7,808,627 $232,697,085 4.95%
7 Tyra Biosciences, Inc. Common Stock TYRA $18.56 N/A 12,198,625 $226,406,480 4.81%
8 Janux Therapeutics, Inc. Common Stock JANX $17.18 N/A 11,189,693 $192,238,926 4.09%
9 SpyGlass Pharma, Inc. Common Stock SGP $23.92 N/A 8,021,117 $191,865,119 4.08%
10 Mineralys Therapeutics, Inc. Common Stock MLYS $21.00 N/A 7,692,750 $161,547,750 3.44%
11 Disc Medicine, Inc. Common Stock IRON $56.60 N/A 2,450,221 $138,682,509 2.95%
12 Zai Lab Limited American Depositary Shares ZLAB $23.10 N/A 5,743,533 $132,675,612 2.82%
13 BioCryst Pharmaceuticals Inc BCRX $8.07 N/A 15,827,186 $127,725,391 2.72%
14 Bicara Therapeutics Inc. Common Stock BCAX $17.34 N/A 7,255,993 $125,818,919 2.68%
15 Xencor, Inc. XNCR $23.52 N/A 5,274,274 $124,050,924 2.64%
16 Oruka Therapeutics, Inc. Common Stock ORKA $78.19 N/A 1,554,597 $121,553,939 2.59%
17 Climb Bio, Inc. Common Stock CLYM $10.31 N/A 11,300,939 $116,512,681 2.48%
18 Artiva Biotherapeutics, Inc. Common Stock ARTV $6.29 N/A 17,955,642 $112,940,988 2.40%
19 Abivax SA American Depositary Shares ABVX $86.22 N/A 1,132,557 $97,649,065 2.08%
20 Wave Life Sciences Ltd. Ordinary Shares WVE $3.14 N/A 26,975,505 $84,703,086 1.80%
Related 13F Filings:
berkshire hathaway 13f,   sec 13f filing list,   warren buffett 13f,   baker brothers 13f,   fundsmith 13f ,   valueact 13f,   greenlight capital 13f,   dorsey asset management 13f,   ra capital 13f,   dragoneer 13f,   vanguard group inc 13f,   hillhouse 13f,   citadel 13f,   morgan stanley 13f,   spruce house 13f,   fmr llc 13f,   sachem head 13f,   duquesne capital 13f,   maverick capital 13f,   soros fund management 13f,   light street capital 13f,   bronte capital 13f,   corvex 13f,   adw capital 13f,   arlington value capital 13f,   greenhaven road capital 13f,   fisher investments 13f,   bares capital management 13f,   generation investment management 13f,   giverny capital 13f,   goldman sachs 13f,   omega advisors 13f,   thomson reuters 13f